Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix + COC in Endometriosis
NCT04333576Phase 3Active, not recruiting
- Sponsor
- AbbVie Inc.
- Start
- Aug 2020
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of elagolix in endometriosis, sponsored by AbbVie Inc.. Started Aug 2020; status: active, not recruiting.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT04333576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04333576.